サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1751191

ヒアルロン酸の市場規模、シェア、動向分析レポート：用途別、地域別、セグメント予測、2025年～2030年

Hyaluronic Acid Market Size, Share & Trends Analysis Report By Application (Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux), By Region (North America, Europe, Asia Pacific), And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.35円
ヒアルロン酸の市場規模、シェア、動向分析レポート：用途別、地域別、セグメント予測、2025年～2030年
出版日: 2025年05月30日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ヒアルロン酸市場の成長と動向：

Grand View Research, Inc.の新しいレポートによると、世界のヒアルロン酸市場規模は2025年から2030年にかけて7.81%のCAGRを記録し、2030年までに167億米ドルに達すると予測されています。

化学物質に対する人々の関心の高まり、迅速で明白な結果を得たいという願望、回復時間の短縮などの要因は、インパクトの強いレンダリング促進要因です。業界は、先進国や開発途上地域での美容施術の採用増加により急速に発展しています。ステントや人工血管のような心臓血管インプラントにおけるヒアルロン酸表面の使用は、アンチエイジング製品に対する意識の高まりと相まって、適合性を向上させるために増加しており、これが成長を後押ししています。

ヒアルロン酸ベースの皮膚充填剤の有効性と明らかな結果が、この人口基盤を引き付けています。さらに、COVID-19の大流行は多くの業界の力学を変え、移動制限、社会的距離、慣行の見直しが"新常識"となっています。化粧品業界が徐々に営業を再開するなか、多くの医師が美容整形手術の問い合わせが大幅に増えたと報告しています。さらに、鎖国によって各専門家がテレビ会議設備を利用するようになり、人々は自分の外見をより意識するようになりました。場合によっては、人々は美容治療を選ぶようになりました。これは"ズーム・ブーム"あるいは"ズーム効果"と呼ばれています。

世界中の美容外科医は、特に米国、オーストラリア、日本などの国々で、パンデミックの結果として患者数が大幅に増加していることを目の当たりにしています。北米は2022年に最大の売上シェアを占めました。高価格であっても短期治療レジメンが好まれること、変形性関節症などの対象疾患の流行が高シェアの主な要因です。2022年、北米地域で最も有利な製品用途は、変形性関節症の管理のための皮膚充填剤とビスコス・サプリメントの形態でした。アジア太平洋地域は、予測期間中に最も速いCAGRを記録すると予想されています。

中国と日本では老年人口が増加しており、アンチエイジング製品およびサービスの大規模な顧客基盤となっています。製品の用途や効能に関する意識の高まりも需要を後押ししています。加えて、可処分所得水準の上昇がこの地域の拡大をさらに後押ししています。欧州は過去2年間に目覚ましい変化を遂げました。需要の拡大により、新規参入企業による価格競争が激化しています。WHOは最近、英国とドイツにおける肥満の蔓延を発表しました。高齢化人口の増加と肥満の関係は、欧州地域セクターの潜在的な原動力です。

ヒアルロン酸市場レポート・ハイライト

  • ダーマル・フィラー部門が市場を独占し、2024年には41.82%の最大収益シェアを獲得。
  • 北米が市場を独占し、2024年には42.08%のシェアを占める。ヒアルロン酸市場は、アンチエイジング治療に対する需要の増加、変形性関節症患者の増加、低侵襲手術に対する意識の高まりによって牽引されています。
  • 米国のヒアルロン酸市場は、非外科的美容処置の需要増加と医療応用、特にヒアルロン酸ベースの皮膚充填剤の進歩に牽引され、力強い成長を遂げています。
  • APACヒアルロン酸市場は予測期間中CAGR 8.25%で成長すると予測される...

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ヒアルロン酸市場の変数、動向、範囲

  • 市場系統の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • ビジネス環境分析
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析
    • パイプライン分析
    • 特許満了分析
    • 価格分析

第4章 ヒアルロン酸市場：用途推定・動向分析

  • 用途別市場シェア、2024年および2030年
  • 用途別セグメントダッシュボード
  • 市場規模、予測、動向分析（用途別、2018～2030年）
    • 皮膚充填剤
    • 変形性関節症
    • 眼科
    • 膀胱尿管逆流症

第5章 ヒアルロン酸市場：地域推定・動向分析

  • 地域別市場シェア分析、2024年および2030年
  • 地域別市場ダッシュボード
  • 市場規模、予測動向分析、2018年から2030年まで：
  • 北米
    • 国別、2018年～2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東およびアフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 参加者概要
  • 企業の市況分析
  • 企業分類
  • 戦略マッピング
  • 企業プロファイル/リスト
    • Allergan
    • Sanofi
    • Genzyme Corporation
    • Anika Therapeutics, Inc.
    • Salix Pharmaceuticals
    • Seikagaku Corporation
    • F. Hoffmann-La Roche Ag
    • Galderma Laboratories LP
    • Zimmer Biomet
    • Smith &Nephew Plc
    • Ferring BV
    • Lifecore Biomedical, Llc
    • HTL Biotechnology
    • Shiseido Company, Limited
    • Bloomage Biotechnology Corporation Limited
    • LG Life Sciences Ltd（LG Chem.）
    • Maruha Nichiro, Inc.
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global hyaluronic acid market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 5 North America hyaluronic acid market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 7 U.S. hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 8 Canada hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 9 Mexico hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 10 Europe hyaluronic acid market, by country, 2018 - 2030 (USD Million)
  • Table 11 Europe hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 12 UK hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 13 Germany hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 14 France hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 15 Italy hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 16 Spain hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 17 Norway hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 18 Denmark hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 19 Sweden hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 20 Asia Pacific hyaluronic acid market, by country, 2018 - 2030 (USD Million)
  • Table 21 Asia Pacific hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 22 Japan hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 23 China hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 24 India hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 25 Australia hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 26 South Korea hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 27 Thailand hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 28 Latin America hyaluronic acid market, by country, 2018 - 2030 (USD Million)
  • Table 29 Latin America hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 30 Brazil hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 31 Argentina hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 32 Middle East & Africa Docetaxel market, by country, 2018 - 2030 (USD Million)
  • Table 33 Middle East & Africa hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 34 South Africa hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 35 Saudi Arabia hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 36 UAE hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 37 Kuwait hyaluronic acid market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Hyaluronic Acid market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Therapeutic approach and application outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Hyaluronic Acid market dynamics
  • Fig. 12 Hyaluronic Acid market: Porter's five forces analysis
  • Fig. 13 Hyaluronic Acid market: PESTLE analysis
  • Fig. 14 Product market, 2018 - 2030 (USD Million)
  • Fig. 15 Dermal fillers market, 2018 - 2030 (USD Million)
  • Fig. 16 Osteoarthritis market, 2018 - 2030 (USD Million)
  • Fig. 17 Ophthalmic market, 2018 - 2030 (USD Million)
  • Fig. 18 Vesicoureteral reflux market, 2018 - 2030 (USD Million)
  • Fig. 19 Regional marketplace: Key takeaways
  • Fig. 20 North America hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 21 U.S. country dynamics
  • Fig. 22 U.S. hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 23 Canada country dynamics
  • Fig. 24 Canada hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 25 Mexico country dynamics
  • Fig. 26 Mexico hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 27 Europe hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 28 UK country dynamics
  • Fig. 29 UK hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 30 Germany country dynamics
  • Fig. 31 Germany hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 32 France country dynamics
  • Fig. 33 France hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 34 Italy country dynamics
  • Fig. 35 Italy hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 36 Spain country dynamics
  • Fig. 37 Spain hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 38 Norway country dynamics
  • Fig. 39 Norway hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 40 Sweden country dynamics
  • Fig. 41 Sweden hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark country dynamics
  • Fig. 43 Denmark hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 44 Asia Pacific hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 45 Japan country dynamics
  • Fig. 46 Japan hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 47 China country dynamics
  • Fig. 48 China hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 49 India country dynamics
  • Fig. 50 India hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 51 Australia country dynamics
  • Fig. 52 Australia hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 53 South Korea country dynamics
  • Fig. 54 South Korea hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 55 Thailand country dynamics
  • Fig. 56 Thailand hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 57 Latin America hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 58 Brazil country dynamics
  • Fig. 59 Brazil hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 60 Argentina country dynamics
  • Fig. 61 Argentina hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 62 MEA hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa country dynamics
  • Fig. 64 South Africa hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 65 Saudi Arabia country dynamics
  • Fig. 66 Saudi Arabia hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 67 UAE country dynamics
  • Fig. 68 UAE hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 69 Kuwait country dynamics
  • Fig. 70 Kuwait hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 71 Company categorization
  • Fig. 72 Company market position analysis
  • Fig. 73 Strategic framework
目次
Product Code: 978-1-68038-333-1

Hyaluronic Acid Market Growth & Trends:

The global hyaluronic acid market size is expected to reach USD 16.7 billion by 2030, registering a CAGR of 7.81% from 2025 to 2030, according to a new report by Grand View Research, Inc. Factors, such as increasing concern of population regarding chemicals, desire to get quick and evident results, and shorter recovery time are high impact rendering drivers. The industry is evolving rapidly due to the increasing adoption of aesthetic procedures in developed and developing regions. Increasing the use of hyaluronic acid surfaces in cardiovascular implants, such as stents and vascular grafts, for improving compatibility coupled with the growing awareness about anti-aging products is fueling the growth.

The efficacy and evident results of hyaluronic acid-based dermal fillers are attracting this population base. Furthermore, the COVID-19 pandemic has changed the dynamics of many industries, with movement restrictions, social distancing, and revised practices becoming the "new normal." As the cosmetic industry is gradually resuming its operations, a number of doctors have reported a significant increase in inquiries for aesthetic surgeries. Moreover, the lockdown has encouraged all professionals to use video-conferencing facilities, which has made people more conscious of their looks. In some cases, it has led people to opt for cosmetic treatments; this is termed the "Zoom Boom" or the "Zoom effect."

Cosmetic surgeons across the world have witnessed a significant increase in the number of patients as a result of the pandemic, particularly in countries, such as the U.S., Australia, and Japan. North America held the maximum revenue share in 2022. Preference for short-treatment regimens, even though high-priced, and the prevalence of target diseases, such as osteoarthritis, are the key factors attributed to the high share. In 2022, the most lucrative product applications in the North America region were in the form of dermal fillers and viscos supplements for the management of osteoarthritis. Asia Pacific is anticipated to register the fastest CAGR during the forecast period.

The growing geriatric population in China and Japan provide a large customer base for anti-aging products and services. Rising awareness about product applications and efficacy also fuels the demand. In addition, increasing disposable income levels are further supporting the region's expansion. Europe has undergone impressive changes over the last 2 years. The growing demand is witnessing increasing price competition owing to new entrants. The WHO recently announced the obesity epidemic in the U.K. and Germany. The relationship between the increasing aging population and obesity is a potential driver for the Europe regional sector

Hyaluronic Acid Market Report Highlights:

  • The dermal fillers segment dominated the market and obtained the largest revenue share of 41.82% in 2024.
  • North America dominated the market and accounted for 42.08% share in 2024. The hyaluronic acid market is driven by increasing demand for anti-aging treatments, rising osteoarthritis cases, and growing awareness of minimally invasive procedures.
  • The U.S. hyaluronic acid market is experiencing robust growth, driven by increasing demand for non-surgical aesthetic procedures and advancements in medical applications, particularly hyaluronic acid-based dermal fillers.
  • APAC hyaluronic acid market is anticipated grow with a CAGR of 8.25% over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. Regional scope
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis
  • 1.8. List of Secondary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Hyaluronic Acid Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTEL Analysis
    • 3.3.3. Pipeline Analysis
    • 3.3.4. Patent Expiry Analysis
    • 3.3.5. Pricing Analysis

Chapter 4. Hyaluronic Acid Market: Application Estimates & Trend Analysis

  • 4.1. Application Market Share, 2024 & 2030
  • 4.2. Application Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analyses, By Application, 2018 to 2030
    • 4.3.1. Dermal fillers
      • 4.3.1.1. Dermal fillers Market 2018 - 2030 (USD Million)
    • 4.3.2. Osteoarthritis
      • 4.3.2.1. Osteoarthritis Market 2018 to 2030 (USD Million)
      • 4.3.2.2. Single-injection
        • 4.4.2.2.1 Single injection Market 2018 to 2030 (USD Million)
      • 4.3.2.3. Three-injection
        • 4.4.2.3.1. Three injection Market 2018 to 2030 (USD Million)
      • 4.3.2.4. Five-injection
        • 4.4.2.3.1. Five injection Market 2018 to 2030 (USD Million)
    • 4.4.3. Ophthalmic
      • 4.4.3.3. Ophthalmic Market 2018 to 2030 (USD Million)
    • 4.4.4. Vesicoureteral reflux
      • 4.4.2.3. Vesicoureteral reflux Market 2018 to 2030 (USD Million)

Chapter 5. Hyaluronic Acid Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Market Share Analysis, 2024 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 5.4. North America
    • 5.5.1. North America Hyaluronic Acid Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 5.5.2. U.S.
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework/
      • 5.5.1.3. Reimbursement structure
      • 5.5.1.4. U.S. Hyaluronic Acid market 2018 to 2030 (USD Million)
    • 5.5.3. Canada
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework
      • 5.5.1.3. Reimbursement structure
      • 5.5.1.4. Canada Hyaluronic Acid market 2018 to 2030 (USD Million)
    • 5.5.4. Mexico
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework
      • 5.5.1.3. Reimbursement structure
      • 5.5.1.4. Mexico Hyaluronic Acid market 2018 to 2030 (USD Million)
  • 5.5. Europe
    • 5.5.1. Europe Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. UK
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Regulatory Framework
      • 5.5.2.3. Reimbursement Framework
      • 5.5.2.4. UK Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. Germany
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Regulatory Framework
      • 5.5.3.3. Reimbursement Framework
      • 5.5.3.4. Germany Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.4. France
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Regulatory Framework
      • 5.5.4.3. Reimbursement Framework
      • 5.5.4.4. France Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.5. Italy
      • 5.5.5.1. Key Country Dynamics
      • 5.5.5.2. Regulatory Framework
      • 5.5.5.3. Reimbursement Framework
      • 5.5.5.4. Italy Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.6. Spain
      • 5.5.6.1. Key Country Dynamics
      • 5.5.6.2. Regulatory Framework
      • 5.5.6.3. Reimbursement Framework
      • 5.5.6.4. Spain Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.7. Denmark
      • 5.5.7.1. Key Country Dynamics
      • 5.5.7.2. Regulatory Framework
      • 5.5.7.3. Reimbursement Framework
      • 5.5.7.4. Denmark Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.8. Sweden
      • 5.5.8.1. Key Country Dynamics
      • 5.5.8.2. Regulatory Framework
      • 5.5.8.3. Reimbursement Framework
      • 5.5.8.4. Sweden Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.9. Norway
      • 5.5.9.1. Key Country Dynamics
      • 5.5.9.2. Regulatory Framework
      • 5.5.9.3. Reimbursement Framework
      • 5.5.9.4. Norway Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Asia Pacific
    • 5.6.1. Asia Pacific Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. Japan
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Regulatory Framework
      • 5.6.2.3. Reimbursement Framework
      • 5.6.2.4. Japan Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.3. China
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Regulatory Framework
      • 5.6.3.3. Reimbursement Framework
      • 5.6.3.4. China Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.4. India
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Regulatory Framework
      • 5.6.4.3. Reimbursement Framework
      • 5.6.4.4. India Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.5. Australia
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Regulatory Framework
      • 5.6.5.3. Reimbursement Framework
      • 5.6.5.4. Australia Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.6. South Korea
      • 5.6.6.1. Key Country Dynamics
      • 5.6.6.2. Regulatory Framework
      • 5.6.6.3. Reimbursement Framework
      • 5.6.6.4. South Korea Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.7. Thailand
      • 5.6.7.1. Key Country Dynamics
      • 5.6.7.2. Regulatory Framework
      • 5.6.7.3. Reimbursement Framework
      • 5.6.7.4. Thailand Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Latin America
    • 5.7.1. Latin America Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.7.2. Brazil
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Regulatory Framework
      • 5.7.2.3. Reimbursement Framework
      • 5.7.2.4. Japan Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.7.3. Argentina
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Regulatory Framework
      • 5.7.3.3. Reimbursement Framework
      • 5.7.3.4. China Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Middle East and Africa
    • 5.8.1. Middle East and Africa Hyaluronic Acid Market Estimates and Forecasts, 2017 - 2030 (USD Million)
    • 5.8.2. South Africa
      • 5.8.2.1. Key Country Dynamics
      • 5.8.2.2. Regulatory Framework
      • 5.8.2.3. Reimbursement Framework
      • 5.8.2.4. South Africa Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.8.3. Saudi Arabia
      • 5.8.3.1. Key Country Dynamics
      • 5.8.3.2. Regulatory Framework
      • 5.8.3.3. Reimbursement Framework
      • 5.8.3.4. Saudi Arabia Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.8.4. UAE
      • 5.8.4.1. Key Country Dynamics
      • 5.8.4.2. Regulatory Framework
      • 5.8.4.3. Reimbursement Framework
      • 5.8.4.4. UAE Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.8.5. Kuwait
      • 5.8.5.1. Key Country Dynamics
      • 5.8.5.2. Regulatory Framework
      • 5.8.5.3. Reimbursement Framework
      • 5.8.5.4. Kuwait Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Participant Overview
  • 6.2. Company Market Position Analysis
  • 6.3. Company Categorization
  • 6.4. Strategy Mapping
  • 6.5. Company Profiles/Listings
    • 6.5.1. Allergan
      • 6.5.1.1. Company overview
      • 6.5.1.2. Financial performance
      • 6.5.1.3. Product benchmarking
      • 6.5.1.4. Strategic initiatives
    • 6.5.2. Sanofi
      • 6.5.2.1. Company overview
      • 6.5.2.2. Financial performance
      • 6.5.2.3. Product benchmarking
      • 6.5.2.4. Strategic initiatives
    • 6.5.3. Genzyme Corporation
      • 6.5.3.1. Company overview
      • 6.5.3.2. Financial performance
      • 6.5.3.3. Product benchmarking
      • 6.5.3.4. Strategic initiatives
    • 6.5.4. Anika Therapeutics, Inc.
      • 6.5.4.1. Company overview
      • 6.5.4.2. Financial performance
      • 6.5.4.3. Product benchmarking
      • 6.5.4.4. Strategic initiatives
    • 6.5.5. Salix Pharmaceuticals
      • 6.5.5.1. Company overview
      • 6.5.5.2. Financial performance
      • 6.5.5.3. Product benchmarking
      • 6.5.5.4. Strategic initiatives
    • 6.5.6. Seikagaku Corporation
      • 6.5.6.1. Company overview
      • 6.5.6.2. Financial performance
      • 6.5.6.3. Product benchmarking
      • 6.5.6.4. Strategic initiatives
    • 6.5.7. F. Hoffmann-La Roche Ag
      • 6.5.7.1. Company overview
      • 6.5.7.2. Financial performance
      • 6.5.7.3. Product benchmarking
      • 6.5.7.4. Strategic initiatives
    • 6.5.8. Galderma Laboratories L.P.
      • 6.5.8.1. Company overview
      • 6.5.8.2. Financial performance
      • 6.5.8.3. Product benchmarking
      • 6.5.8.4. Strategic initiatives
    • 6.5.9. Zimmer Biomet
      • 6.5.9.1. Company overview
      • 6.5.9.2. Financial performance
      • 6.5.9.3. Product benchmarking
      • 6.5.9.4. Strategic initiatives
    • 6.5.10. Smith & Nephew Plc
      • 6.5.10.1. Company overview
      • 6.5.10.2. Financial performance
      • 6.5.10.3. Product benchmarking
      • 6.5.10.4. Strategic initiatives
    • 6.5.11. Ferring B.V.
      • 6.5.11.1. Company overview
      • 6.5.11.2. Financial performance
      • 6.5.11.3. Product benchmarking
      • 6.5.11.4. Strategic initiatives
    • 6.5.12. Lifecore Biomedical, Llc
      • 6.5.12.1. Company overview
      • 6.5.12.2. Financial performance
      • 6.5.12.3. Product benchmarking
      • 6.5.12.4. Strategic initiatives
    • 6.5.13. HTL Biotechnology
      • 6.5.13.1. Company overview
      • 6.5.13.2. Financial performance
      • 6.5.13.3. Product benchmarking
      • 6.5.13.4. Strategic initiatives
    • 6.5.14. Shiseido Company, Limited
      • 6.5.14.1. Company overview
      • 6.5.14.2. Financial performance
      • 6.5.14.3. Product benchmarking
      • 6.5.14.4. Strategic initiatives
    • 6.5.15. Bloomage Biotechnology Corporation Limited
      • 6.5.15.1. Company overview
      • 6.5.15.2. Financial performance
      • 6.5.15.3. Product benchmarking
      • 6.5.15.4. Strategic initiatives
    • 6.5.16. LG Life Sciences Ltd (LG Chem.)
      • 6.5.16.1. Company overview
      • 6.5.16.2. Financial performance
      • 6.5.16.3. Product benchmarking
      • 6.5.16.4. Strategic initiatives
    • 6.5.17. Maruha Nichiro, Inc.
      • 6.5.17.1. Company overview
      • 6.5.17.2. Financial performance
      • 6.5.17.3. Product benchmarking
      • 6.5.17.4. Strategic initiatives